Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

Litium - Report in line with estimates

13 februari 2025

<a id="bm-comp-a5ed1eea-af2f-4d4f-acac-61be07f8b983" name="bm-comp-a5ed1eea-af2f-4d4f-acac-61be07f8b983" class="BMCustomAnchor"></a><table><tr><td bm-component-id="a5ed1eea-af2f-4d4f-acac-61be07f8b983" style="vertical-align: top; width:100.000000%;"><ul><li>Sales slightly above ABGSCe, ARR in line</li><li>Limited consensus estimate revisions are likely</li><li>Variable revenue on the rise</li></ul></td></tr></table><a id="bm-comp-98456d86-2d82-43e2-ae8a-a95a67b0ac47" name="bm-comp-98456d86-2d82-43e2-ae8a-a95a67b0ac47" class="BMCustomAnchor"></a><table><tr><td bm-component-id="98456d86-2d82-43e2-ae8a-a95a67b0ac47" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Q4'24 report</h3><p>Litium reported an ARR of SEK 72.3m (+/-0% vs. ABGSCe ~72m), net sales of SEK 19.5m (+3% vs. ABGSCe 19m) and EBITDA of SEK 4.9m (+2% vs. ABGSCe 4.8m). Overall, the report was in line with our estimates. We are positively surprised by the increase in the variable revenue, which suggests that client volumes are recovering.</p><h3 class="bm-h3">Thoughts and outlook</h3><p>Litium has so far benefited from its fixed revenue base. However, the benefit of variable revenues could materialise as client volumes appear to recover (as evidenced by a larger share of variable revenues). It is now more evident that business momentum is improving and that the company's pipeline is strong. CEO Patrik Settlin is leaving the company, to be replaced by Martin Billenius, a member of the board, with previous SaaS experience. All that said, our view of the company's operating characteristics remain unchanged and somewhat more positive than previously due to the increasing variable revenue share.</p><h3 class="bm-h3">Cons. estimate revisions and valuation</h3><p>Based on the first impressions from the report, we anticipate consensus to make limited revisions. The company is trading at an EV/ARR of ~2x based on reported figures. Litium will host a <a href="https://www.finwire.tv/webcast/litium/bokslutskommunike-2024/" target="_blank">webcast</a> today at 11:00 CET to present the Q4 report and to conduct a Q&amp;A session.</p><table id="bm-img-3bdfd885-4c84-4a84-9653-e6e1a509bbd9" class="bm-img-table xslt-img-empty xslt-img-include"><tr><td class="xslt-img-caption">Deviation table</td></tr><tr><td><img bm-img-encrypt="3bdfd885-4c84-4a84-9653-e6e1a509bbd9" bm-img-original-height="580" bm-img-original-width="984" bm-img-svg="image:image_upload/85474_9c82558a-0aa4-418b-a148-21b03675fd61.svg" bm-img-width-hint="100%" id="bm-id-3bdfd885-4c84-4a84-9653-e6e1a509bbd9" src="https://abgsc.bluematrix.com/images/image_upload/85474_9c82558a-0aa4-418b-a148-21b03675fd61_727.png" svg="/nas/web/clients/abgsc/images/image_upload/85474_9c82558a-0aa4-418b-a148-21b03675fd61.svg" width="727" alt="" title="" /></td></tr><tr><td class="xslt-img-source">Source: ABG Sundal Collier, Company data.</td></tr></table><br /></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2025-03-27 IRLAB Therapeutics - IRL757 starts Ph 1b IRLAB Thera.. Analys
2025-03-21 Proact - Deploying capital in the UK Proact Analys
2025-03-21 Rottneros - PW: wood costs, FX, and CTMP Rottneros Analys
2025-03-18 Infrea - Adopts financial targets Infrea Analys
2025-03-18 Petrolia Noco - Brage reserve uplift boosts produ... Petrolia Noco Analys
2025-03-14 North Media - Negative EV, allocation policy need... North Media Analys
2025-03-14 North Media - Q4 investment return better than ex... North Media Analys
2025-03-13 Nolato - CMD recap: back to earnings growth focus Nolato Analys
2025-03-13 Nolato - New targets ahead of CMD Nolato Analys
2025-03-12 Clavister - We raise estimates on good activity Clavister Analys
2025-03-11 Qben Infra - Riding the wave of infra spending Qben Infra Analys
2025-03-10 North Media - Rationale of SDR increasingly quest... North Media Analys
2025-03-10 Lumi Gruppen - Capitalising on education trends Lumi Gruppen Analys
2025-03-07 North Media - SDR once again the bad guy North Media Analys
2025-03-06 Ogunsen - Battling a challenging market Ogunsen Analys
2025-03-06 BTS Group - We expect improvements ahead BTS Group Analys
2025-03-05 IRLAB Therapeutics - Pirepemat fails Ph 2b REACT-PD IRLAB Thera.. Analys
2025-03-05 Tempest Security - Transformative year, time to l... Tempest Sec.. Analys
2025-03-05 Careium - Careium wins SEK 24m Norwegian contract Careium Analys
2025-03-05 NYAB - Impressive execution NYAB Analys